Overview
Medicofarma Biotech is a company listed on NewConnect that focuses on the development of innovative drugs, medical devices, and biotechnology products aimed at preventing and treating lifestyle diseases. It offers research and development services and routine analyses for the pharmaceutical, cosmetic, food, and chemical sectors through its contract laboratory. The company is also involved in projects related to cancer therapies and the creation of plant-based medicinal products.
Financials
Revenue history (in k)
Data and insights are generated automatically based on financial statements and may contain errors. This analysis is for informational purposes only and does not constitute an official assessment of the company's credibility or business advice.
Stock quotes
- Open
- PLN 0.38
- High
- PLN 0.38
- Low
- PLN 0.36
- Volume
- 13.17K
- Avg. vol.
- 18.78K
- Market cap
- PLN 25.83M
- P/E ratio
- –
- EPS
- -PLN 0.03
- Shares outstanding
- 67.98M
- 52-week
- PLN 0.34 – 0.41
- Dividend yield
- –
- Dividend
- –
- Ex dividend date
- –
- ISIN
- PLINBOK00010
- Exchange
- NewConnect
Quarterly results
| Period | Revenue | EBIT | Net profit |
|---|---|---|---|
| Q2 2026 | USD 9.18k | USD -162.34k | USD -162.34k |
| Q1 2026 | USD 9.72k | USD -154.78k | USD -155.05k |
| Q4 2025 | USD 2.01k | USD 127.83k | USD -28.88k |
| Q3 2025 | USD 28.13k | USD -184.58k | USD -184.58k |
Results for Q3 2026:Nov 10, 2026
Statistics
How the company ranks by revenue within its industry, region and across Poland in 2025.
Results vs industry
News
Medicofarma Biotech opened a new laboratory in Poznań
Inwestycje.pl: Medicofarma Biotech opened an R&D Center in Poznań
Bankier.pl: Medicofarma Biotech wants to move to the main GPW market
Biotechnologia.pl: Medicofarma Biotech reveals development plans for the coming years
Forsal.pl: Plans for Biotech's entry to the main GPW market
Stockwatch.pl: Medicofarma Biotech's goal: systematic increase in company value
Industry
Bank accounts
Registered as a VAT taxpayer on 2001-06-01. Active
Debt
No entries in the National Debtors Register (KRZ). No proceedings in KRZ
Real estate
| Type | Amount |
|---|---|
Land (incl. perpetual usufruct) | $130.5K$130,492 |
Buildings and premises | $1.1M$1,127,261 |
Public aid
9 public aid cases recorded, with a total value of $866,075.
| Grant date | Purpose | Gross amount | Granting body | |
|---|---|---|---|---|
| Jan 7, 2026 | De minimis aid (in accordance with Commission Regulation 2023/2831) | $845$845 | PGE Obrót S.A. | |
| Sep 20, 2023 | Aid for research and development projects: experimental development | $579.1K$579,139 | Dyrektor Narodowego Centrum Badań i Rozwoju | |
| Sep 20, 2023 | Aid for research and development projects: industrial research | $276.3K$276,291 | Dyrektor Narodowego Centrum Badań i Rozwoju |
Tenders
No recorded participation in tenders.
Regulatory authorisations
| Authority | Type | Status | |
|---|---|---|---|
 KNF | Consumer credit intermediary | Active |
Authorized Representatives
Manner of representation
Each member of the management board has the right to represent the company independently.
Supervisory board
Beneficial owners
| Person | Rights |
|---|---|
Competitors
| Name | Revenue | Website | ||
|---|---|---|---|---|
| Ecoverseasp. z o.o. | $891,022.45 | coslab.pl | ||
| CTI Clinical Trial And Consulting Services Polandsp. z o.o. | $527,145.56 | ctifacts.com | ||
| Orphinic ScientificS.A. | $518,429.97 | orphinic.com | ||
| Proper Medical Writingsp. z o.o. | $514,848.41 | propermedicalwriting.com | ||
| MedisensonicS.A. | $362,572.63 | medisensonic.com | ||
| Green ZebrasS.A. | $328,658.91 | whygreenzebras.pl | ||
| CCTSsp. z o.o. | $281,193.31 | ccts.pl | ||
| Frontline BiosciencesS.A. | $219,186.29 | frontlinebiosciences.com | ||
| TCIsp. z o.o. | $218,471.87 | tci.pl | ||
| FcbiotechS.A. | $148,945.77 | fcbiotech.pl |
Change history
| Date | Event | |
|---|---|---|
| 2021-09-16 | Address change (Ul. Walentego Roździeńskiego 11, 41-308, Dąbrowa Górnicza → Ul. Sokołowska 9/U19, 01-142, Warszawa) | |
| 2021-06-25 | Share capital change (679,783.00 PLN → 6,797,830.00 PLN) | |
| 2021-03-15 | PKD change (Removed: 47.61.Z, 47.62.Z, 47.63.Z, 47.91.Z, 62.09.Z, 74.20.Z; Added: 20.13.Z, 20.14.Z, 20.59.Z, 21.20.Z, 46.46.Z, 71.20.B, 72.11.Z, 72.19.Z, 74.90.Z, 77.40.Z) | |
| 2021-02-01 | Name change ("inbook" → Medicofarma Biotech) | |
| 2017-07-12 | Address change (Osiedle Robotnicze 6, 42-520, Dąbrowa Górnicza → Ul. Walentego Roździeńskiego 11, 41-308, Dąbrowa Górnicza) |
FAQ
Last updated: 2026-10-03